Advertisement

Drugmaker announces immuno-oncology startup with New Zealand university

By Lydia Coutre, Crain's Cleveland Business  |  January 18, 2017

BioMotiv, a Cleveland-based drug development accelerator associated with The Harrington Project, and a university in New Zealand have announced the formation of an immuno-oncology startup that will work to develop a suite of cancer vaccines.

Data Points: Sharp drop-off in new drugs approved

Data Points: Sharp drop-off in new drugs approved

By Modern Healthcare  |  January 07, 2017

Approvals for new drugs dropped to a six-year low in 2016. Industry insiders are optimistic that the recently passed 21st Century Cures Act will speed up the process.

Drug companies will be fined for overcharging 340B hospitals

Drug companies will be fined for overcharging 340B hospitals

By Virgil Dickson  |  January 04, 2017

The Obama administration has finalized a rule that imposes fines on drug companies that overcharge hospitals and clinics for medication purchased under the government's 340B drug discount program.

The 2016 Year in Review: Drugs and devices

The 2016 Year in Review: Drugs and devices

By Adam Rubenfire  |  December 17, 2016

Insurers, providers, policymakers, employers and consumer groups spent much of 2016 blasting the pharmaceutical industry's pricing of prescription drugs.

Mylan launches cheaper version of EpiPen allergy treatment

By Associated Press  |  December 16, 2016

The launch of Mylan's long-promised generic alternative is expected to still generate millions of dollars in revenue for the drugmaker while also protecting its market share against current and future competition.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.